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Innovations
Tol
Agroup of NIEHS
researchers recently
developed a revolution-
ary tool that will boost scientists'
ability to analyze how human genes
change in response to environmental
agents. The ToxChip, a complementary
DNA (cDNA) microarray chip, will allow
life sciences researchers to monitor the
expression levels of thousands of different
genes at a time, thereby condensing
months of painstaking laboratory tasks
into a day's work. For toxicology
researchers in particular, this tool is an
important development because it promis-
es a more effective way to identify envi-
ronmental hazards and their effects on
DNA. The ToxChip could transform the
way toxicologists approach environmental
problems.
NIEHS scientific director J. Carl
Barrett, Cynthia Afshari, director of the
NIEHS cDNA Microarray Laboratory,
and postdoctoral fellow Emile F.
Nuwaysir, working with Jeff Trent and
colleagues at the National Human
Genome Research Institute, pioneered the
ToxChip technique for studying toxicolo-
gy. According to the scientists, the cloned
cDNA microarrays measure gene expres-
sion, which in turn serves as a highly sen-
sitive and informative marker for toxicity.
The ToxChip allows greater sensitivity in
detecting the effects of harmful com-
pounds, the researchers say. At the same
time, it will significantly trim the amount
of time needed to gauge how these com-
pounds affect biological systems.
The NIEHS team hopes that investiga-
tors will soon be able to use the ToxChip
to determine the relative safety ofnatural or
synthesized compounds for human expo-
sure and to study how chemical mixtures
interact. Further down the road, the
ToxChip may be useful in helping to pre-
vent diseases caused by environmental
exposures besides detecting toxic respons-
es in human tissues and other organism
models such as mice, rats, and yeast, these
microarrays could be used to speed clinical
trials for potential new drugs and even sug-
gest optimal dosages for treatment.
The collective work of the NIEHS
group and other researchers around the
United States who are conducting related
studies has engendered a new scientific
subdiscipline called toxicogenomics. This
blend of toxicology and genomics makes
use of genomics resources (namely, the
huge GenBank database of DNA sequence
information that has been compiled over
the last decade or so) to advance one main
goal: identifying potential human and
environmental toxicants and their modes
of action.
"There has been a revolution in the
economy ofscale," says Nuwaysir, referring
to the fact that scientists
than 30,000 of the possible
70,000-100,000 total genes.
The GenBank database. which
includes the complete genomic sequence
of 17 individual organisms, boasts a verita-
ble gold mine of genetic informatioin. TO
more fully extract these riches, howxcsrer,
scientists needed a faster and farther-reach-
ing tool. Afshari and Nuwaysir ptit their
heads together to tailor available microarray
chip technology to achieve parallel moni-
toring of gene expression in an application
for toxicology. Traditional methods-
including Northern blotting, RNase pro-
tection assays, S1 nuclease analysis, plaque
hybridization, and slot blots are tedious
and time-consuming. Using these methods,
an investigator typically studies one gene at
a time. The sheer amount of genetic infor-
mation available to be analyzed today ren-
ders these methods inappropriate and pos-
sibly obsolete. The ToxChip, however, can
monitor expression levels for thousands of
genes simultaneously. "What's novel about
this technique is its scale," Ntiwaysir
asserts. "And it can be applied to almost
any question in biology."
Decoding Mechanisms ofResponse
Toxicity almost always alters gene expres-
sion, either directly or indirectly. With the
ToxChip, researchers can quickly and
methodically run experiments to analyzv
the characteristic and specific pattern of
gene expression caused by a particular tox-
icant. The result is a toxicant "signature,?
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or a common set of changes in gene
expression caused by a certain class oftox-
icant. Once these various signatures are
established, researchers can compare them
to the gene expression profiles caused by
unknown agents in the same model sys-
tem. When a match is found, a presumed
mechanism of action is assigned to the
toxicant being tested.
The ToxChip contains genes that
exhibit changes resulting from what
Nuwaysir refers to as "very basic, classic,
well-studied agents." These include oxi-
dant stressors, which are important from a
pathological standpoint; dioxin and diox-
in-like compounds such as 2,3,7,8-tetra-
chlorodibenzo-p-dioxin, a known carcino-
gen; peroxisome proliferators; and envi-
ronmental estrogens. "We look for charac-
teristic changes, then see if the unknowns
line up, if there is a subset that matches.
It's a way to predict a mechanism or mode
ofaction," he explains.
"We trick normal cellular machinery
into doing our work for us," Nuwaysir
says, referring to the manner in which the
complementary nucleic acids from each of
the two cDNA groups (from a normal cell
and tumor cell, for example) present on
the chip will adhere to one another.
"Basically, we're exploitingwhat nature has
already perfected," he adds. "It's like two
people finding each other in a crowded bus
terminal." Each of the minuscule dots on
the glass chip contains concentrated copies
ofthe same genetic material, so they func-
tion as "magnets," attracting the comple-
mentary pieces of DNA
floating around in solution
on the chip.
The control and test doned
cDNA groups are tagged
with different fluorescent
nucleotides, one groupwith
green and the other with
red. Then, the cDNA
groups produced from the
control and test popula-
tions are commingled and
hybridized onto the chip
under a glass coverslip.
During hybridization, each
cDNA in solution binds
specifically to the cDNAon
the chip that is its perfect
complement.
Next, a scanning con-
focal microscope with a
motorized stage and lasers A microarray of
to excite the fluors detects Carl Barrett (clo
the fluorescent signal. collected usingth
Lasers-first red, then green-pass
beneath the chip, revealing the matches
between the control and test cDNA
groups. Attached to the microscope is a
computer equipped with custom digital
image analysis software, which sifts
through the data and determines the ratio
ofthe two different fluors (red to green) at
each cDNA feature on the chip.
According to Nuwaysir, green intensity
signals expression of the gene in the con-
trol sample, while red intensity signals
expression of the gene in the treated, or
test, sample. "The color of one particular
gene does not necessarily indicate toxici-
ty," he says. "However, the color pattern
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for many genes can be associated with a
toxic condition."
Afshari, Nuwaysir, and their colleagues
are working on version 2.0 of the
ToxChip, which would organize 12,000
individual genes on one chip. Other chips
in the works will study other model sys-
tems, such as rats, mice, frogs, and yeast,
all ofwhich could eventually be employed
in toxicology studies.
While the NIEHS lab has been devel-
oping the ToxChip specifically for use in
toxicological studies, other scientists have
been working on similar technologies to
meet other goals. "This whole approach is
very generic," says Kevin Becker, head of
z
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E HowtheToxChipWorks
ToxChip version 1.0 features
a subarray ofclones of2,100
human genes, which were
selected because they are
involved in basic cellular
processes and are proven to
respond to different types of
toxic injury. Large quantities
of each gene clone are pro-
duced through polymerase
chain reaction. Using high-
speed robotics, microarrays
of up to 10,000 clones are
etched onto a glass substrate,
ormicrochip.
When it's time to test a
particular toxicant, fluores-
cent nucleotide probes are
generated from control and
test RNA samples through
the single-round reverse tran-
scription reaction process.
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Red light. green light. Using ToxChip, gene expression data are derived from exposure of model systems to known toxicants
(GroupA, B, and C genes). These data are compared to a setof gene expression changes elicited by a suspected toxicant. If
the characteristics match, a putative mechanism of action can be assigned tothe unknown agent.
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the DNA Array Unit
at the National Insti-
tute on Aging in
Baltimore, Maryland.
"The technology is
the same as in our
chip," he adds, refer-
ring to the DNA
microarray chips he
and his colleagues
have been developing,
but, he says, "Our
[chip] is more dis-
ease-focused."
Weighing the Pros
and Cons
Generating vast quan-
titles of toxicogenom-
ic data quickly is one
thing. Sorting and
analyzing it once it's
in hand is another
matter entirely. One
must decide exactly
what to do with the
information or deter-
mine the next ques-
tion that needs to be
asked. Both Afshari
and Nuwaysir con-
cede that these tasks
can be extremely dif-
ficult. The technique
produces a staggering
volume of raw data
for scientists to
observe. One chip
Aoptsis
Cell cycle control
Cytochromes
Dioxin/polycyclic aromatic
hydrocarbon responsive
DNA replication and repair
Estrogen responsive
Heatshock proteins
Housekeeping
Kinases
Oncogenes and tumor suppressor
genes
Oxidative stress and redox
homeostasis
P450s
Peroxisome proliferator responsive
Phdosphatases
Receptors
Transcription factors
*Some genes may notbe represented intheir respective
categories ormaybe represented in multiple categories.
alone a slender piece of glass measuring
75 mm by 25 mm and just 1 mm thick and
holding an array that measures approxi-
mately 35 mm by 15 mm yields thou-
sands of data points. "That means hun-
dreds of thousands of data points in a
week," says Afshari. "That's where the
informatics has to be put into place. For
example, we will need specialized software
to analyze the computer output of the
image files, combined with sophisticated
software that has clustering algorithms to
allow us to determine
patterns of gene
expression across
doses or time points."
The technology
has a few other hur-
dles to leap, as well.
First, it requires sig-
nificant amounts of
the DNA that is
spotted onto the chip
and the RNA used to
probe the chip.
Second, it can be dif-
ficult to distinguish
between two gene
family members that
have very similar
DNA sequences.
Third, one machine
can scan only 8-12
chips in any given
workday, so even
though output is
high (as measured in
data gleaned from
each chip), the actual
throughput (the
number of chips
scanned) is low.
That's a disadvantage
that can be overcome
only by equipping
the lab with addi-
tional expensive
scanning machines,
which cost anywhere
from $40,000 to
more than $100,000, or by developing
newer, high-throughput technologies.
Still, the ToxChip brings many advan-
tages to science. It may reduce researchers'
dependence on animals to complete some
toxicological studies. Traditional bioassays
require the use of many animals to ade-
quately study one research question.
Animal studies also require lots of time. A
rodent cancer bioassay, for example, may
last four years, expending 1,200 animals
and millions of dollars in the process.
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While the ToxChip won't replace animal
studies entirely, it could give valuable
information to help a researcher do a bet-
ter job of tailoring a bioassay to the toxi-
cological agent being studied, potentially
reducing the amount of money, time, and
animals necessary to complete it.
Screening with the ToxChip, when
used to complement a bioassay, may also
enable researchers to lower toxicant
dosages in studies to a level that more
closely resembles typical human exposure
levels. Microarrays may help researchers
explore the connection between acute and
chronic toxicity and identify presumed
secondary effects by looking at the rela-
tionship between the length of exposure
and the gene expression profiles generated
by that toxicant. This could mean shorter
bioassays, more realistic test dosages, and
considerable cost savings when compared
with typical assays.
Perhaps its chief advantage is that the
ToxChip can help give scientists a sense of
the bigger picture. "It allows researchers to
see the organization of the genome and its
response to a disease state or chemical
insult," Nuwaysir says. Until now,
researchers have been limited to studying
one gene at a time, one gel at a time, one
week at a time in a serial process that pro-
ceeds at an often-slow, inexorable pace.
With the advent of this newest microarrav
chip technology, one researcher can ana-
lyze 10,000 genes in one day.
Becker says the technology 'allows for
the simultaneous analysis of many, many
things." In the past, he explains, when sci-
entists discovered a new gene, it was
tempting for them to believe that one gene
would hold the answers to nmany ques-
tions. "It's usually much more complicat-
ed than that," he says. "Now researchers
can't fall into that trap."
A larger genetic perspective should help
researchers understand patterns of respons-
es in genes to toxic agents. As Afshari sees
it, the essential work of all biologists is to
look for patterns. Much work remains to
be done, both in the NIEHS lab and in
other research labs dedicated to developing
and using the technology. For instance,
Afshari says, researchers using the technol-
ogy could benefit from better statistical
methods for pattern recognition and gene
clustering. She and her NIEHS colleagues
have spent the last two years fine-tuning
the ToxChip. Now, she concludes, "what
we need is computers and software to help
us find the patterns that show where
behaviors fall together."
Jennifer F. Medlin
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